New patent for Clovis Oncology drug RUBRACA

   November 24, 2020    Comments Off on New patent for Clovis Oncology drug RUBRACA    Posted in: Patent Added

Annual Drug Patent Expirations for RUBRACA Rubraca is a drug marketed by Clovis Oncology Inc and is included in one NDA. It is available from one supplier. There are twelve…

The post New patent for Clovis Oncology drug RUBRACA appeared first on DrugPatentWatch - Make Better Decisions.

  

Comments are closed.

Biotechblog